Trial Details
RECRUITINGBasic Information
| Clinical ID | c1197 |
|---|---|
| Identifier | NCT05181137 |
| Trial Title | A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: SHR0302|DRUG: Placebo |
Participant Information
| Sponsor | Reistone Biopharma Company Limited |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-11-05 |
|---|---|
| Primary Completion Date | 2024-10-31 |
| Completion Date | 2025-03-31 |